← Back to TXG

10x Genomics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 07/08/2026Sep 2025Filed 07/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 07/08/2026Sep 2024Filed 07/11/2025Jun 2024Filed 07/11/2025Mar 2024Filed 07/11/2025
$151$151$149$173$155$152$153$141
−$18−$13−$27$35−$34−$36−$38−$60
−$0.14−$0.10−$0.22$0.28−$0.28−$0.30−$0.32−$0.50
130128126125123121120119

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.